Status:
COMPLETED
Smart Watch, Heart Rate and So2 in Chronic Patients
Lead Sponsor:
Umm Al-Qura University
Conditions:
Chronic Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Background: Apple watch validity to measure the heart rate (HR) and oxygen saturation (Spo2) in healthy subjects has been investigated, but its accuracy and validity for patients with chronic non-comm...
Detailed Description
Introduction: Assessment of the heart rate (HR) is an essential process to determine proper exercise training intensity. (1) Utilization of the 12-leads electrocardiogram (ECG) is considered most obj...
Eligibility Criteria
Inclusion
- eligible participants will be patients with chronic diseases as those with:
- Stable diabetes mellitus type 1 or 2.
- Hypertension but not more than 180 mm.Hg
- Hyperlipidemia
Exclusion
- patients with :
- Uncontrolled diabetes mellitus.
- Uncontrolled hypertension.
- Uncontrolled hyperlipidemia will be all excluded from the study.
- Patient with other chronic diseases rather than that described in the inclusion criteria will be also excluded.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT05271864
Start Date
November 1 2022
End Date
July 30 2023
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Umm Al-Qura medical center
Al Makhwāh, Mecca Region, Saudi Arabia, 21234